Biotech Values

[iwfal]

Niacin -

Perhaps of more concern was the five times difference in major adverse events, defined as heart attack, death from heart disease, need for artery-clearing procedures or hospitalization for acute coronary syndrome, although the numbers were small.

FWIW this is about p=0.06 by Fisher's Exact (and it would be stat sig by Bernard's Exact, which I consider a better test). Which is amazing in a trial of 360 people (but not a complete surprise to me - see my post from 2 years ago (where I referred to it as the second coming for CAD))